Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 127.21 USD 0.94%
Market Cap: 7.3B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Ascendis Pharma A/S
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ascendis Pharma A/S
Total Assets Peer Comparison

Comparables:
GMAB
ZEAL
B
BAVA
F
FLUO
BIOPOR

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Ascendis Pharma A/S
NASDAQ:ASND
Total Assets
€758.3m
CAGR 3-Years
-4%
CAGR 5-Years
0%
CAGR 10-Years
44%
Genmab A/S
CSE:GMAB
Total Assets
kr38.6B
CAGR 3-Years
20%
CAGR 5-Years
34%
CAGR 10-Years
30%
Zealand Pharma A/S
CSE:ZEAL
Total Assets
kr9.6B
CAGR 3-Years
80%
CAGR 5-Years
41%
CAGR 10-Years
39%
B
Bavarian Nordic A/S
CSE:BAVA
Total Assets
kr14.3B
CAGR 3-Years
13%
CAGR 5-Years
40%
CAGR 10-Years
28%
F
Fluoguide AS
STO:FLUO
Total Assets
kr29.6m
CAGR 3-Years
21%
CAGR 5-Years
230%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Total Assets
kr131.5m
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
12%

See Also

What is Ascendis Pharma A/S's Total Assets?
Total Assets
758.3m EUR

Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's Total Assets amounts to 758.3m EUR.

What is Ascendis Pharma A/S's Total Assets growth rate?
Total Assets CAGR 10Y
44%

Over the last year, the Total Assets growth was -8%. The average annual Total Assets growth rates for Ascendis Pharma A/S have been -4% over the past three years , and 44% over the past ten years .

Back to Top